Targeting telomeres and telomerase.

Telomeres and telomerase represent, at least in theory, an extremely attractive target for cancer therapy. The objective of this review is to present the latest view on the mechanism(s) of action of telomerase inhibitors, with an emphasis on a specific class of telomere ligands called G-quadruplex ligands, and to discuss their potential use in oncology.

[1]  Yan Xu,et al.  The new models of the human telomere d[AGGG(TTAGGG)3] in K+ solution. , 2006, Bioorganic & medicinal chemistry.

[2]  K. Shin‐ya,et al.  Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia , 2006, Oncogene.

[3]  E. De Pauw,et al.  Ascididemin and meridine stabilise G-quadruplexes and inhibit telomerase in vitro. , 2005, Biochimica et biophysica acta.

[4]  A. Schnapp,et al.  Mechanism of Human Telomerase Inhibition by BIBR1532, a Synthetic, Non-nucleosidic Drug Candidate* , 2002, The Journal of Biological Chemistry.

[5]  C. Renner,et al.  Neomycin-capped aromatic platforms: quadruplex DNA recognition and telomerase inhibition. , 2006, Organic & biomolecular chemistry.

[6]  J. Shay,et al.  The involvement of the Mre11/Rad50/Nbs1 complex in the generation of G‐overhangs at human telomeres , 2006, EMBO reports.

[7]  I. Thorey,et al.  A Novel Regulator of Telomerase , 2007, Journal of Biological Chemistry.

[8]  M. Lanotte,et al.  Retinoic acid receptor α and retinoid-X receptor-specific agonists synergistically target telomerase expression and induce tumor cell death , 2003, Oncogene.

[9]  B. Gilchrest,et al.  T‐oligos augment UV‐induced protective responses in human skin , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  C. Günes,et al.  Telomeres and telomerase. A survey about methods and recent advances in cancer diagnostic and therapy. , 2006, Histology and histopathology.

[11]  M. Cerone,et al.  Telomere maintenance by telomerase and by recombination can coexist in human cells. , 2001, Human molecular genetics.

[12]  N. Farrell,et al.  Cross-links of quadruplex structures from human telomeric DNA by dinuclear platinum complexes show the flexibility of both structures. , 2005, Biochemistry.

[13]  M. Lanotte,et al.  Diagnostics, prognostic and therapeutic exploitation of telomeres and telomerase in leukemias. , 2006, Current Pharmaceutical Biotechnology.

[14]  P. Klatt,et al.  Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis. , 2007, Genes & development.

[15]  H. Jernberg-Wiklund,et al.  Interferon-induced sensitization to apoptosis is associated with repressed transcriptional activity of the hTERT promoter in multiple myeloma. , 2006, Biochemical and biophysical research communications.

[16]  Phang-lang Chen,et al.  Assembly of functional ALT-associated promyelocytic leukemia bodies requires Nijmegen Breakage Syndrome 1. , 2003, Cancer research.

[17]  S. Neidle,et al.  Structure-based design of benzylamino-acridine compounds as G-quadruplex DNA telomere targeting agents. , 2007, Bioorganic & medicinal chemistry letters.

[18]  E. Raymond,et al.  Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells. , 1999, Cancer research.

[19]  Yunfeng Zhou,et al.  Radiosensitization effect of zidovudine on human malignant glioma cells. , 2007, Biochemical and biophysical research communications.

[20]  P. Bates,et al.  Antiproliferative Activity of G-rich Oligonucleotides Correlates with Protein Binding* , 1999, The Journal of Biological Chemistry.

[21]  L. Hurley,et al.  Accurate determination of quadruplex binding affinity and potency of G-quadruplex-interactive telomerase inhibitors by use of a telomerase extension assay requires varying the primer concentration. , 1999, Anti-cancer drug design.

[22]  J. Mergny,et al.  Targeting human telomerase for cancer therapeutics , 2004, Cytotechnology.

[23]  E. De Pauw,et al.  Interactions of cryptolepine and neocryptolepine with unusual DNA structures. , 2003, Biochimie.

[24]  Jan Postberg,et al.  Telomere end-binding proteins control the formation of G-quadruplex DNA structures in vivo , 2005, Nature Structural &Molecular Biology.

[25]  Chao Xing,et al.  Adult-onset pulmonary fibrosis caused by mutations in telomerase , 2007, Proceedings of the National Academy of Sciences.

[26]  Jung-whan Kim,et al.  IFN‐γ/IRF‐1‐induced p27 kip1 down‐regulates telomerase activity and human telomerase reverse transcriptase expression in human cervical cancer , 2005 .

[27]  J. Mergny,et al.  The importance of metal geometry in the recognition of G-quadruplex-DNA by metal-terpyridine complexes. , 2007, Organic & biomolecular chemistry.

[28]  N. Munshi,et al.  Effects of oligonucleotide N3'-->P5' thio-phosphoramidate (GRN163) targeting telomerase RNA in human multiple myeloma cells. , 2003, Cancer research.

[29]  M. Blasco,et al.  Porphyrin-aminoquinoline conjugates as telomerase inhibitors. , 2003, Organic & biomolecular chemistry.

[30]  K. Collins.  The biogenesis and regulation of telomerase holoenzymes , 2006, Nature Reviews Molecular Cell Biology.

[31]  K. Collins,et al.  A telomerase component is defective in the human disease dyskeratosis congenita , 1999, Nature.

[32]  T. Cech,et al.  POT1 Stimulates RecQ Helicases WRN and BLM to Unwind Telomeric DNA Substrates* , 2005, Journal of Biological Chemistry.

[33]  J. Chow,et al.  Small-molecule c-Myc inhibitor, 10058-F4, inhibits proliferation, downregulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells , 2007, Anti-cancer drugs.

[34]  Marie C. M. Lin,et al.  Cancer immunotherapy targeting the telomerase reverse transcriptase. , 2006, Cellular & molecular immunology.

[35]  M. Cerone,et al.  Mutated telomeres sensitize tumor cells to anticancer drugs independently of telomere shortening and mechanisms of telomere maintenance , 2006, Oncogene.

[36]  H. Seimiya.  The telomeric PARP, tankyrases, as targets for cancer therapy , 2006, British Journal of Cancer.

[37]  S. Neidle,et al.  1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase. , 1998, Journal of medicinal chemistry.

[38]  A. Multani,et al.  POT1b protects telomeres from end‐to‐end chromosomal fusions and aberrant homologous recombination , 2006, The EMBO journal.

[39]  U. K. Laemmli,et al.  Specific targeting of insect and vertebrate telomeres with pyrrole and imidazole polyamides , 2001, The EMBO journal.

[40]  Stephen Neidle,et al.  The design of G-quadruplex ligands as telomerase inhibitors. , 2003, Mini reviews in medicinal chemistry.

[41]  Stephen Neidle,et al.  The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function. , 2005, Cancer research.

[42]  L. S. Cram,et al.  A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[43]  S. Neidle,et al.  Natural and synthetic G-quadruplex interactive berberine derivatives. , 2006, Bioorganic & medicinal chemistry letters.

[44]  Sarah A. Compton,et al.  Xrcc3 and Nbs1 are required for the production of extrachromosomal telomeric circles in human alternative lengthening of telomere cells. , 2007, Cancer research.

[45]  James M. Morrell,et al.  Evaluation of by disubstituted acridone derivatives as telomerase inhibitors: the importance of G-quadruplex binding. , 2004, Bioorganic & medicinal chemistry letters.

[46]  Julie E Reed,et al.  Stabilization of G-quadruplex DNA and inhibition of telomerase activity by square-planar nickel(II) complexes. , 2006, Journal of the American Chemical Society.

[47]  K. Shin‐ya,et al.  Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathways , 2003, Oncogene.

[48]  T. Lange,et al.  DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion , 2005, Nature Cell Biology.

[49]  M. Yuen,et al.  Inhibition of human telomerase reverse transcriptase by nonsteroidal antiinflammatory drugs in colon carcinoma , 2006, Cancer.

[50]  E. Gilson,et al.  Natural and pharmacological regulation of telomerase. , 2002, Nucleic acids research.

[51]  M. Lanotte,et al.  Telomeres and telomerase: Pharmacological targets for new anticancer strategies? , 2006, Current cancer drug targets.

[52]  M. Vodenicharov,et al.  DNA degradation at unprotected telomeres in yeast is regulated by the CDK1 (Cdc28/Clb) cell-cycle kinase. , 2006, Molecular cell.

[53]  S. Akinaga,et al.  Telomerase inhibitors identified by a forward chemical genetics approach using a yeast strain with shortened telomere length. , 2006, Chemistry & biology.

[54]  Jessie C. Jeyapalan,et al.  Tumour‐cell apoptosis after cisplat in treatment is not telomere dependent , 2006, International journal of cancer.

[55]  T. Bryan,et al.  Physiological relevance of telomeric G‐quadruplex formation: a potential drug target , 2007, BioEssays : news and reviews in molecular, cellular and developmental biology.

[56]  A. Jauch,et al.  The multi-step process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1. , 2007, European journal of cell biology.

[57]  Dan Liu,et al.  TPP1 is a homologue of ciliate TEBP-β and interacts with POT1 to recruit telomerase , 2007, Nature.

[58]  J. Shay,et al.  Antiadhesive effects of GRN163L--an oligonucleotide N3'->P5' thio-phosphoramidate targeting telomerase. , 2007, Cancer research.

[59]  M. Fraga,et al.  DNA methyltransferases control telomere length and telomere recombination in mammalian cells , 2006, Nature Cell Biology.

[60]  E. Gilson,et al.  A topological mechanism for TRF2-enhanced strand invasion , 2007, Nature Structural &Molecular Biology.

[61]  M. Hande,et al.  Telomere and Telomerase Modulation by the Mammalian Rad9/Rad1/Hus1 DNA-Damage-Checkpoint Complex , 2006, Current Biology.

[62]  S. Aamdal,et al.  Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer , 2006, Cancer Immunology, Immunotherapy.

[63]  R. Reddel,et al.  Telomere elongation in immortal human cells without detectable telomerase activity. , 1995, The EMBO journal.

[64]  Roger A. Jones,et al.  Human telomeric sequence forms a hybrid-type intramolecular G-quadruplex structure with mixed parallel/antiparallel strands in potassium solution , 2006, Nucleic acids research.

[65]  Jiangqin Zhao,et al.  Involvement of NF‐Y and Sp1 binding sequences in basal transcription of the human telomerase RNA gene , 2003, FEBS letters.

[66]  D. Corey,et al.  Identification of determinants for inhibitor binding within the RNA active site of human telomerase using PNA scanning. , 1997, Biochemistry.

[67]  Ping Wang,et al.  A Phenol Quaternary Ammonium Porphyrin as a Potent Telomerase Inhibitor by Selective Interaction with Quadruplex DNA , 2006, Chembiochem : a European journal of chemical biology.

[68]  D. Broccoli,et al.  p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. , 1999, Science.

[69]  S. Balasubramanian,et al.  Inhibition of human telomerase activity by an engineered zinc finger protein that binds G-quadruplexes. , 2004, Biochemistry.

[70]  D. Corey,et al.  Inhibition of human telomerase activity by peptide nucleic acids , 1996, Nature Biotechnology.

[71]  Yuan-Ming Yeh,et al.  Potent inhibition of human telomerase by helenalin. , 2005, Cancer letters.

[72]  C. Price,et al.  Tetrahymena POT1a Regulates Telomere Length and Prevents Activation of a Cell CycleCheckpoint , 2006, Molecular and Cellular Biology.

[73]  Danila Coradini,et al.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. , 2005, Cancer research.

[74]  I. Chung,et al.  Identification of a quinoxaline derivative that is a potent telomerase inhibitor leading to cellular senescence of human cancer cells. , 2003, The Biochemical journal.

[75]  T. Tollefsbol,et al.  Evidence of extra-telomeric effects of hTERT and its regulation involving a feedback loop. , 2007, Experimental cell research.

[76]  G. Nelson,et al.  TRF2 overexpression diminishes repair of telomeric single-strand breaks and accelerates telomere shortening in human fibroblasts , 2007, Mechanisms of Ageing and Development.

[77]  J. Qin,et al.  Telosome, a Mammalian Telomere-associated Complex Formed by Multiple Telomeric Proteins* , 2004, Journal of Biological Chemistry.

[78]  J. Griffith,et al.  Mammalian Telomeres End in a Large Duplex Loop , 1999, Cell.

[79]  E. Carpenter,et al.  Telomerase-based immunotherapy of cancer , 2006, Expert opinion on biological therapy.

[80]  S. Kyo,et al.  Estrogen activates telomerase. , 1999, Cancer research.

[81]  Y. Kondo,et al.  2-5A antisense telomerase RNA therapy for intracranial malignant gliomas. , 2000, Cancer research.

[82]  Dan Liu,et al.  A critical role for TPP1 and TIN2 interaction in high-order telomeric complex assembly , 2006, Proceedings of the National Academy of Sciences.

[83]  P. Bates,et al.  Biophysical and biological properties of quadruplex oligodeoxyribonucleotides. , 2003, Nucleic acids research.

[84]  David Lydall,et al.  A Genome-Wide Screen Identifies the Evolutionarily Conserved KEOPS Complex as a Telomere Regulator , 2006, Cell.

[85]  D. Trisciuoglio,et al.  Involvement of hTERT in apoptosis induced by interference with Bcl-2 expression and function , 2005, Cell Death and Differentiation.

[86]  K. Hasegawa,et al.  Expression of cyclooxygenase-2 in uterine endometrial cancer and anti-tumor effects of a selective COX-2 inhibitor. , 2005, International journal of oncology.

[87]  P. Lou,et al.  A Novel Carbazole Derivative, BMVC: a Potential Antitumor Agent and Fluorescence Marker of Cancer Cells , 2004, Chemistry & biodiversity.

[88]  E. Blackburn,et al.  The effects of nucleoside analogs on telomerase and telomeres in Tetrahymena. , 1994, Nucleic acids research.

[89]  G. Ortaggi,et al.  Selective interactions of perylene derivatives having different side chains with inter- and intramolecular G-quadruplex DNA structures. A correlation with telomerase inhibition. , 2005, Bioorganic & medicinal chemistry letters.

[90]  M. Tsuchiya,et al.  Isothiazolone derivatives selectively inhibit telomerase from human and rat cancer cells in vitro. , 1999, Biochemistry.

[91]  Hamid Morjani,et al.  Telomestatin-induced Telomere Uncapping Is Modulated by POT1 through G-overhang Extension in HT1080 Human Tumor Cells* , 2006, Journal of Biological Chemistry.

[92]  H. Sugiyama,et al.  Specific alkylation of human telomere repeats by hairpin pyrrole-imidazole polyamide. , 2003, Bioorganic & medicinal chemistry.

[93]  C. Tseng,et al.  hTERT phosphorylation by PKC is essential for telomerase holoprotein integrity and enzyme activity in head neck cancer cells , 2006, British Journal of Cancer.

[94]  G. Sledge,et al.  Telomerase Template Antagonist GRN163L Disrupts Telomere Maintenance, Tumor Growth, and Metastasis of Breast Cancer , 2006, Clinical Cancer Research.

[95]  S. Neidle,et al.  Design, synthesis and evaluation of human telomerase inhibitors based upon a tetracyclic structural motif. , 1999, Anti-cancer drug design.

[96]  T. Lange,et al.  Homologous Recombination Generates T-Loop-Sized Deletions at Human Telomeres , 2004, Cell.

[97]  J. Mergny,et al.  Apoptosis related to telomere instability and cell cycle alterations in human glioma cells treated by new highly selective G-quadruplex ligands , 2005, Oncogene.

[98]  B. Gilchrest,et al.  Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides. , 2004, Experimental cell research.

[99]  B. Freeman,et al.  The p23 molecular chaperone promotes functional telomerase complexes through DNA dissociation , 2007, Proceedings of the National Academy of Sciences.

[100]  I. Hickson,et al.  Inhibition of the Bloom's and Werner's syndrome helicases by G-quadruplex interacting ligands. , 2001, Biochemistry.

[101]  Jean-Louis Mergny,et al.  G-quadruplex DNA: A target for drug design , 1998, Nature Medicine.

[102]  N. Carter,et al.  A DNA damage checkpoint response in telomere-initiated senescence , 2003, Nature.

[103]  C. Heaphy,et al.  Telomeres: Prognostic markers for solid tumors , 2006, International journal of cancer.

[104]  T. Cech,et al.  The POT1–TPP1 telomere complex is a telomerase processivity factor , 2007, Nature.

[105]  R. Deng,et al.  Senescence and telomere shortening induced by novel potent G-quadruplex interactive agents, quindoline derivatives, in human cancer cell lines , 2006, Oncogene.

[106]  R. Reddel,et al.  Coexistence of Alternative Lengthening of Telomeres and Telomerase in hTERT-Transfected GM847 Cells , 2001, Molecular and Cellular Biology.

[107]  K. Anderson,et al.  Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myeloma. , 2003, Molecular cancer therapeutics.

[108]  T. Tsuruo,et al.  Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo. , 2003, Cancer research.

[109]  E. Blackburn,et al.  Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines , 1996, Molecular and cellular biology.

[110]  Iris Cheung,et al.  Disruption of dog-1 in Caenorhabditis elegans triggers deletions upstream of guanine-rich DNA , 2002, Nature Genetics.

[111]  B. Gilchrest,et al.  Induction of apoptosis by telomere 3' overhang-specific DNA. , 2002, Experimental cell research.

[112]  T. Tsuruo,et al.  Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins. , 1998, Biochemical and biophysical research communications.

[113]  J. Shay,et al.  Effects of a novel telomerase inhibitor, GRN163L, in human breast cancer , 2006, Breast Cancer Research and Treatment.

[114]  M. Blasco,et al.  Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres , 2007, Nature Genetics.

[115]  M. Lanotte,et al.  Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[116]  D. Patel,et al.  Solution structure of the human telomeric repeat d[AG3(T2AG3)3] G-tetraplex. , 1993, Structure.

[117]  S. Bombard,et al.  Platinum cross-linking of adenines and guanines on the quadruplex structures of the AG3(T2AG3)3 and (T2AG3)4 human telomere sequences in Na+ and K+ solutions. , 2003, Nucleic acids research.

[118]  M. Mann,et al.  ERCC1/XPF removes the 3' overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes. , 2003, Molecular cell.

[119]  S. Sasaki,et al.  Development of novel telomerase inhibitors based on a bisindole unit. , 2001, Bioorganic & medicinal chemistry letters.

[120]  G. Ortaggi,et al.  New highly hydrosoluble and not self-aggregated perylene derivatives with three and four polar side-chains as G-quadruplex telomere targeting agents and telomerase inhibitors. , 2007, Bioorganic & medicinal chemistry letters.

[121]  B. Guyen,et al.  Synthesis and evaluation of analogues of 10H-indolo[3,2-b]quinoline as G-quadruplex stabilising ligands and potential inhibitors of the enzyme telomerase. , 2004, Organic & biomolecular chemistry.

[122]  S. Neidle,et al.  A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity. , 2002, Molecular pharmacology.

[123]  R. Reddel,et al.  Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference , 2007, Oncogene.

[124]  G. Morin.  The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats , 1989, Cell.

[125]  Stephen Neidle,et al.  Crystal structure of parallel quadruplexes from human telomeric DNA , 2002, Nature.

[126]  K. Nakatani,et al.  Small‐Molecule Binding to the Nonquadruplex Form of the Human Telomeric Sequence , 2007, Chembiochem : a European journal of chemical biology.

[127]  B. Dutrillaux,et al.  Preferential binding of a G-quadruplex ligand to human chromosome ends , 2005, Nucleic acids research.

[128]  G. Ortaggi,et al.  Perylene diimides with different side chains are selective in inducing different G-quadruplex DNA structures and in inhibiting telomerase. , 2002, Bioorganic & medicinal chemistry letters.

[129]  Louise Fairall,et al.  How the human telomeric proteins TRF1 and TRF2 recognize telomeric DNA: a view from high‐resolution crystal structures , 2005, EMBO reports.

[130]  K. Shin‐ya,et al.  Telomestatin, a novel telomerase inhibitor from Streptomyces anulatus. , 2001, Journal of the American Chemical Society.

[131]  A. Jauch,et al.  Telomere dysfunction as a cause of genomic instability in Werner syndrome , 2007, Proceedings of the National Academy of Sciences.

[132]  T. Lange,et al.  DNA Damage Foci at Dysfunctional Telomeres , 2003, Current Biology.

[133]  S. Mackay,et al.  Molecular modelling and cytotoxicity of substituted anthraquinones as inhibitors of human telomerase. , 2002, Bioorganic & medicinal chemistry.

[134]  J. Shay,et al.  In vivo inhibition of lung cancer by GRN163L: a novel human telomerase inhibitor. , 2005, Cancer research.

[135]  I Berger,et al.  In vitro generated antibodies specific for telomeric guanine-quadruplex DNA react with Stylonychia lemnae macronuclei , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[136]  D. Sun,et al.  G-quadruplex DNA binding by a series of carbocyanine dyes. , 2001, Bioorganic & medicinal chemistry letters.

[137]  Charles A Laughton,et al.  Antitumor polycyclic acridines. 8.(1) Synthesis and telomerase-inhibitory activity of methylated pentacyclic acridinium salts. , 2002, Journal of medicinal chemistry.

[138]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[139]  Yung-Hyun Choi.  Apoptosis of U937 human leukemic cells by sodium butyrate is associated with inhibition of telomerase activity. , 2006, International journal of oncology.

[140]  J. Langmore,et al.  Long G Tails at Both Ends of Human Chromosomes Suggest a C Strand Degradation Mechanism for Telomere Shortening , 1997, Cell.

[141]  L. Neckers.  Using natural product inhibitors to validate Hsp90 as a molecular target in cancer. , 2006, Current topics in medicinal chemistry.

[142]  S. Neidle,et al.  Human telomerase inhibition by substituted acridine derivatives. , 1999, Bioorganic & medicinal chemistry letters.

[143]  K. Shin‐ya,et al.  Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase. , 2003, Cancer research.

[144]  Dinshaw J. Patel,et al.  Structure of the human telomere in K+ solution: an intramolecular (3 + 1) G-quadruplex scaffold. , 2006, Journal of the American Chemical Society.

[145]  K. Shin‐ya,et al.  G-Quadruplex stabilization by telomestatin induces TRF2 protein dissociation from telomeres and anaphase bridge formation accompanied by loss of the 3′ telomeric overhang in cancer cells , 2006, Oncogene.

[146]  R. Wellinger,et al.  The terminal DNA structure of mammalian chromosomes , 1997, The EMBO journal.

[147]  Sarah A. Compton,et al.  Induction of Nitric Oxide Synthase-Dependent Telomere Shortening after Functional Inhibition of Hsp90 in Human Tumor Cells , 2006, Molecular and Cellular Biology.

[148]  J. Campisi,et al.  TIN2 Mediates Functions of TRF2 at Human Telomeres* , 2004, Journal of Biological Chemistry.

[149]  R. Gartenhaus,et al.  Telomere uncapping by the G-quadruplex ligand RHPS4 inhibits clonogenic tumour cell growth in vitro and in vivo consistent with a cancer stem cell targeting mechanism , 2007, British Journal of Cancer.

[150]  Jinguo Huang,et al.  Quaternary Ammonium Zinc Phthalocyanine: Inhibiting Telomerase by Stabilizing G quadruplexes and Inducing G‐Quadruplex Structure Transition and Formation , 2007, Chembiochem : a European journal of chemical biology.

[151]  J. Mergny,et al.  Telomerase downregulation induced by the G-quadruplex ligand 12459 in A549 cells is mediated by hTERT RNA alternative splicing. , 2004, Nucleic acids research.

[152]  G. Evan,et al.  Genetic Analysis of Myc and Telomerase Interactions In Vivo , 2006, Molecular and Cellular Biology.

[153]  B. Zhu,et al.  8‐chloroadenosine induced HL‐60 cell growth inhibition, differentiation, and G0/G1 arrest involves attenuated cyclin D1 and telomerase and up‐regulated p21WAF1/CIP1 , 2006, Journal of cellular biochemistry.

[154]  A. Phan,et al.  (3 + 1) Assembly of three human telomeric repeats into an asymmetric dimeric G-quadruplex. , 2005, Journal of the American Chemical Society.

[155]  L. Meng,et al.  Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor. , 2005, Biochemical and biophysical research communications.

[156]  G. Ulaner.  Telomere maintenance in clinical medicine. , 2004, The American journal of medicine.

[157]  T. von Zglinicki,et al.  Telomeres as biomarkers for ageing and age-related diseases. , 2005, Current molecular medicine.

[158]  O. Fedoroff,et al.  Induction of Duplex to G-quadruplex Transition in the c-myc Promoter Region by a Small Molecule* , 2001, The Journal of Biological Chemistry.

[159]  P. Lansdorp,et al.  Regulation of Murine Telomere Length by Rtel An Essential Gene Encoding a Helicase-like Protein , 2004, Cell.

[160]  P. Boukamp,et al.  Telomeres rather than telomerase a key target for anti‐cancer therapy? , 2007, Experimental dermatology.

[161]  Lin Ma,et al.  Synthesis and evaluation of quindoline derivatives as G-quadruplex inducing and stabilizing ligands and potential inhibitors of telomerase. , 2005, Journal of medicinal chemistry.

[162]  J. Sedivy.  Telomeres limit cancer growth by inducing senescence: long-sought in vivo evidence obtained. , 2007, Cancer cell.

[163]  Z. Jia,et al.  The effect of 17 sesquiterpenes on cell viability and telomerase activity in the human ovarian cancer cell line HO-8910. , 2007, Planta medica.

[164]  Jean-Louis Mergny,et al.  Detection of telomerase inhibitors based on g-quadruplex ligands by a modified telomeric repeat amplification protocol assay. , 2002, Cancer research.

[165]  Stephen Neidle,et al.  Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[166]  Chao-Po Lin,et al.  G-quadruplexes induce apoptosis in tumor cells. , 2006, Cancer research.

[167]  Laurence H. Hurley,et al.  Facilitation of a structural transition in the polypurine/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex-interactive agents , 2005, Nucleic acids research.

[168]  M. Valenti,et al.  Amino-bisphosphonates decrease hTERT gene expression in breast cancer in vitro , 2007, Aging clinical and experimental research.

[169]  O. Olivero.  Mechanisms of genotoxicity of nucleoside reverse transcriptase inhibitors , 2007, Environmental and molecular mutagenesis.

[170]  Gaël Cristofari,et al.  Telomere length homeostasis requires that telomerase levels are limiting , 2006, The EMBO journal.

[171]  I. Viano,et al.  Cis-[Pt(Cl)2(pyridine)(5-SO3H-isoquinoline)] complex, a selective inhibitor of telomerase enzymea , 2003, Biometals.

[172]  L. Kèlland,et al.  Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects. , 2005, European journal of cancer.

[173]  M. Blasco.  Telomeres and human disease: ageing, cancer and beyond , 2005, Nature Reviews Genetics.

[174]  M. Blasco,et al.  A G-quadruplex ligand with 10000-fold selectivity over duplex DNA. , 2007, Journal of the American Chemical Society.

[175]  J. Shay,et al.  POT1 protects telomeres from a transient DNA damage response and determines how human chromosomes end , 2005, The EMBO journal.

[176]  S. Bombard,et al.  Platination of the (T2G4)4 telomeric sequence: a structural and cross-linking study. , 2001, Biochemistry.

[177]  K. Shin‐ya,et al.  Resistance to the Short Term Antiproliferative Activity of the G-quadruplex Ligand 12459 Is Associated with Telomerase Overexpression and Telomere Capping Alteration* , 2003, Journal of Biological Chemistry.

[178]  M. Bissell,et al.  p53-dependent integration of telomere and growth factor deprivation signals , 2007, Proceedings of the National Academy of Sciences.

[179]  H. Leffers,et al.  Identification of two human nuclear proteins that recognise the cytosine-rich strand of human telomeres in vitro. , 2000, Nucleic acids research.

[180]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[181]  Walter Kolch,et al.  Transcriptional repression of telomerase RNA gene expression by c-Jun-NH2-kinase and Sp1/Sp3. , 2006, Cancer research.

[182]  D. Corey,et al.  Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[183]  M. Cerone,et al.  A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT , 2005, Oncogene.

[184]  W. Hahn,et al.  Inhibition of telomerase limits the growth of human cancer cells , 1999, Nature Medicine.

[185]  K. Dubrana,et al.  Telomeres and telomerase as targets for anticancer drug development. , 2006, Critical reviews in oncology/hematology.

[186]  I. Hickson,et al.  DNA helicases required for homologous recombination and repair of damaged replication forks. , 2006, Annual review of genetics.

[187]  D. Broccoli,et al.  Telomerase Inhibition Using Azidothymidine in the HT-29 Colon Cancer Cell Line , 2003, Annals of Surgical Oncology.

[188]  T. Tollefsbol,et al.  The low-toxicity 9-cis UAB30 novel retinoid down-regulates the DNA methyltransferases and has anti-telomerase activity in human breast cancer cells. , 2007, International journal of oncology.

[189]  S. Bombard,et al.  GG sequence of DNA and the human telomeric sequence react with cis-diammine-diaquaplatinum at comparable rates. , 2007, Journal of Inorganic Biochemistry.

[190]  M. Blasco.  The epigenetic regulation of mammalian telomeres , 2007, Nature Reviews Genetics.

[191]  J. Zahm,et al.  Overexpression of Bcl-2 is associated with apoptotic resistance to the G-quadruplex ligand 12459 but is not sufficient to confer resistance to long-term senescence , 2005, Nucleic acids research.

[192]  D. Bearss,et al.  Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[193]  P. Bates,et al.  Antiproliferative activity of G-quartet-forming oligonucleotides with backbone and sugar modifications. , 2002, Biochemistry.

[194]  Carol W. Greider,et al.  Identification of a specific telomere terminal transferase activity in tetrahymena extracts , 1985, Cell.

[195]  E. Gilson,et al.  The Apollo 5′ Exonuclease Functions Together with TRF2 to Protect Telomeres from DNA Repair , 2006, Current Biology.

[196]  G. Starace,et al.  The length of telomeric G-rich strand 3'-overhang measured by oligonucleotide ligation assay. , 2001, Nucleic acids research.

[197]  E. Blackburn,et al.  Genes and pathways downstream of telomerase in melanoma metastasis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[198]  F. Moretti,et al.  Signaling through estrogen receptors modulates telomerase activity in human prostate cancer. , 2002, The Journal of clinical investigation.

[199]  J. Mergny,et al.  Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[200]  A. Phan,et al.  Different loop arrangements of intramolecular human telomeric (3+1) G-quadruplexes in K+ solution , 2006, Nucleic acids research.

[201]  L. Elmore,et al.  Telomerase inhibition as an adjuvant anticancer therapy: it is more than just a waiting game , 2007, Expert opinion on therapeutic targets.

[202]  G. Kroemer,et al.  hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway , 2006, Oncogene.

[203]  Q. Qi,et al.  Inhibition of human telomerase reverse transcriptase gene expression by gambogic acid in human hepatoma SMMC-7721 cells. , 2006, Life sciences.

[204]  Patrick Mailliet,et al.  Stabilization of the c-myc gene promoter quadruplex by specific ligands' inhibitors of telomerase. , 2004, Biochemical and biophysical research communications.

[205]  J. Shay,et al.  Normal human chromosomes have long G-rich telomeric overhangs at one end. , 1997, Genes & development.

[206]  K. Shin‐ya,et al.  Interaction of Telomestatin with the Telomeric Single-strand Overhang* , 2004, Journal of Biological Chemistry.

[207]  N. Ikeda,et al.  Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity , 2005, International journal of urology : official journal of the Japanese Urological Association.

[208]  J. Chaires,et al.  Interaction of an Acridine Dimer with DNA Quadruplex Structures , 2001, Journal of biomolecular structure & dynamics.

[209]  David M. Prescott,et al.  Inhibition of telomerase by G-quartet DMA structures , 1991, Nature.

[210]  Ian D. Hickson,et al.  The Bloom's and Werner's syndrome proteins are DNA structure-specific helicases , 2001, Nucleic Acids Res..

[211]  Paula J. Bates,et al.  AGRO100 inhibits activation of nuclear factor-κB (NF-κB) by forming a complex with NF-κB essential modulator (NEMO) and nucleolin , 2006, Molecular Cancer Therapeutics.

[212]  B. Gilchrest,et al.  Features that determine telomere homolog oligonucleotide‐induced therapeutic DNA damage‐like responses in cancer cells , 2007, Journal of cellular physiology.

[213]  W. Wilson,et al.  Telomestatin and diseleno sapphyrin bind selectively to two different forms of the human telomeric G-quadruplex structure. , 2005, Journal of the American Chemical Society.

[214]  R. Weiss,et al.  Need telomere maintenance? Call 911 , 2007, Cell Division.

[215]  T. Lange,et al.  Apollo, an Artemis-Related Nuclease, Interacts with TRF2 and Protects Human Telomeres in S Phase , 2006, Current Biology.

[216]  D. V. Von Hoff,et al.  G-quadruplexes as targets for drug design. , 2000, Pharmacology & therapeutics.

[217]  M. Stevens,et al.  Antitumour polycyclic acridines. Palladium(0) mediated syntheses of quino[4,3,2-kl]acridines bearing peripheral substituents as potential telomere maintenance inhibitors. , 2003, Organic & biomolecular chemistry.

[218]  R. Glasspool,et al.  Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters. , 2005, Cancer research.

[219]  Guoqiang Chen,et al.  Immunodetection of human telomerase reverse-transcriptase (hTERT) re-appraised: nucleolin and telomerase cross paths , 2006, Journal of Cell Science.

[220]  C. Autexier,et al.  The structure and function of telomerase reverse transcriptase. , 2006, Annual review of biochemistry.

[221]  G. Gaudernack,et al.  Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I/II study , 2006, British Journal of Cancer.

[222]  D. Feldser,et al.  Short telomeres limit tumor progression in vivo by inducing senescence. , 2007, Cancer cell.

[223]  M. Cerone,et al.  Telomerase inhibition enhances the response to anticancer drug treatment in human breast cancer cells , 2006, Molecular Cancer Therapeutics.

[224]  K. Shin‐ya,et al.  The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in human cells. , 2006, Cancer research.

[225]  T. Iwasaka,et al.  The tea polyphenol, (-)-epigallocatechin gallate effects on growth, apoptosis, and telomerase activity in cervical cell lines. , 2004, Gynecologic oncology.

[226]  G. Mills,et al.  Telomere 3′ overhang‐specific DNA oligonucleotides induce autophagy in malignant glioma cells , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[227]  P. Hornsby.  Senescence as an anticancer mechanism. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[228]  Sandy Chang,et al.  WRN at telomeres: implications for aging and cancer , 2007, Journal of Cell Science.

[229]  C. Greider.  Telomerase RNA levels limit the telomere length equilibrium. , 2006, Cold Spring Harbor symposia on quantitative biology.

[230]  J. Shay,et al.  Telomere-end processing the terminal nucleotides of human chromosomes. , 2005, Molecular cell.

[231]  N. Bache,et al.  Protein Composition of Catalytically Active Human Telomerase from Immortal Cells , 2007, Science.

[232]  N. Maizels,et al.  The Bloom’s Syndrome Helicase Unwinds G4 DNA* , 1998, The Journal of Biological Chemistry.

[233]  M. Bakhanashvili,et al.  Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell lines , 2005, British Journal of Cancer.

[234]  S. Neidle,et al.  Structure-activity relationships among guanine-quadruplex telomerase inhibitors. , 2000, Pharmacology & therapeutics.

[235]  M. Lanotte,et al.  A novel mechanism of retinoic acid resistance in acute promyelocytic leukemia cells through a defective pathway in telomerase regulation , 2002, Leukemia.

[236]  B. Gilchrest,et al.  Induction of a p95/Nbs1‐mediated S phase checkpoint by telomere 3′ overhang specific DNA , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[237]  C. Harley,et al.  Lipid modification of GRN163, an N3′ → P5′ thio-phosphoramidate oligonucleotide, enhances the potency of telomerase inhibition , 2005, Oncogene.

[238]  K. Shin‐ya,et al.  The telomerase inhibitor telomestatin induces telomere shortening and cell death in Arabidopsis. , 2006, Biochimica et biophysica acta.

[239]  S. Neidle,et al.  2,7-Disubstituted amidofluorenone derivatives as inhibitors of human telomerase. , 1999, Journal of medicinal chemistry.

[240]  S. Chen‐Kiang,et al.  Telomerase inhibition with an oligonucleotide telomerase template antagonist: in vitro and in vivo studies in multiple myeloma and lymphoma. , 2004, Blood.

[241]  J. Mergny,et al.  Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[242]  U. Martens,et al.  The level of telomere dysfunction determines the efficacy of telomerase-based therapeutics in a lung cancer cell line. , 2005, International journal of oncology.

[243]  P. Klatt,et al.  High-throughput telomere length quantification by FISH and its application to human population studies , 2007, Proceedings of the National Academy of Sciences.

[244]  I. Chung,et al.  Potent inhibition of human telomerase by nitrostyrene derivatives. , 2003, Molecular pharmacology.

[245]  W. Hahn,et al.  Telomerase Maintains Telomere Structure in Normal Human Cells , 2003, Cell.

[246]  H. Hirte,et al.  Induction of hTERT Expression and Telomerase Activity by Estrogens in Human Ovary Epithelium Cells , 2000, Molecular and Cellular Biology.

[247]  R. Wheelhouse,et al.  Quadruplex-interactive agents as telomerase inhibitors: synthesis of porphyrins and structure-activity relationship for the inhibition of telomerase. , 2001, Journal of medicinal chemistry.

[248]  B. Cathers,et al.  Inhibition of human telomerase by 7-deaza-2'-deoxyguanosine nucleoside triphosphate analogs: potent inhibition by 6-thio-7-deaza-2'-deoxyguanosine 5'-triphosphate. , 2001, Bioorganic chemistry.

[249]  A. Schnapp,et al.  A highly selective telomerase inhibitor limiting human cancer cell proliferation , 2001, The EMBO journal.

[250]  W. Hahn,et al.  The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[251]  S Neidle,et al.  Molecular modeling studies on G-quadruplex complexes of telomerase inhibitors: structure-activity relationships. , 1999, Journal of medicinal chemistry.

[252]  D. Corey,et al.  Inhibition of human telomerase by 2'-O-methyl-RNA. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[253]  Yuying Liang,et al.  Functional characterization of natural telomerase mutations found in patients with hematologic disorders. , 2007, Blood.

[254]  P. Lou,et al.  Detection of quadruplex DNA structures in human telomeres by a fluorescent carbazole derivative. , 2004, Analytical chemistry.

[255]  M. Tsuchiya,et al.  A novel platinum compound inhibits telomerase activity in vitro and reduces telomere length in a human hepatoma cell line , 2003, International journal of cancer.

[256]  M. Mattson,et al.  Telomere Protection Mechanisms Change during Neurogenesis and Neuronal Maturation: Newly Generated Neurons Are Hypersensitive to Telomere and DNA Damage , 2007, The Journal of Neuroscience.

[257]  Hsu-Shan Huang,et al.  Synthesis and human telomerase inhibition of a series of regioisomeric disubstituted amidoanthraquinones. , 2007, Chemical & pharmaceutical bulletin.

[258]  Hong Zhang.  Molecular signaling and genetic pathways of senescence: Its role in tumorigenesis and aging , 2007, Journal of cellular physiology.

[259]  M. Blasco,et al.  Porphyrin Derivatives for Telomere Binding and Telomerase Inhibition , 2005, Chembiochem : a European journal of chemical biology.

[260]  James M. Morrell,et al.  Trisubstituted acridine derivatives as potent and selective telomerase inhibitors. , 2003, Journal of medicinal chemistry.

[261]  D. Wynford‐Thomas,et al.  Extensive allelic variation and ultrashort telomeres in senescent human cells , 2003, Nature Genetics.

[262]  C. Autexier,et al.  Pharmacological Telomerase Inhibition Can Sensitize Drug-Resistant and Drug-Sensitive Cells to Chemotherapeutic Treatment , 2005, Molecular Pharmacology.

[263]  J. Mergny,et al.  Benzoindoloquinolines interact with DNA tetraplexes and inhibit telomerase. , 2002, Bioorganic & medicinal chemistry letters.

[264]  T. Tsuruo,et al.  Telomere shortening and growth inhibition of human cancer cells by novel synthetic telomerase inhibitors MST-312, MST-295, and MST-1991. , 2002, Molecular cancer therapeutics.

[265]  K. Pongracz,et al.  Allosteric inhibitors of telomerase: oligonucleotide N3'-->P5' phosphoramidates. , 2002, Nucleic acids research.

[266]  Jean-Louis Mergny,et al.  A New Steroid Derivative Stabilizes G-Quadruplexes and Induces Telomere Uncapping in Human Tumor Cells , 2007, Molecular Pharmacology.

[267]  L. Loeb,et al.  Human Werner Syndrome DNA Helicase Unwinds Tetrahelical Structures of the Fragile X Syndrome Repeat Sequence d(CGG) n * , 1999, The Journal of Biological Chemistry.

[268]  Brian D. Freibaum,et al.  hSnm1B Is a Novel Telomere-associated Protein* , 2006, Journal of Biological Chemistry.

[269]  U. Martens,et al.  Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532. , 2005, Blood.

[270]  M. Manns,et al.  Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma , 2005, Hepatology.

[271]  E. De Pauw,et al.  Selective interaction of ethidium derivatives with quadruplexes: an equilibrium dialysis and electrospray ionization mass spectrometry analysis. , 2003, Biochemistry.

[272]  G. Ortaggi,et al.  Specific interactions with intra- and intermolecular G-quadruplex DNA structures by hydrosoluble coronene derivatives: a new class of telomerase inhibitors. , 2007, Bioorganic & medicinal chemistry.

[273]  T. Zglinicki,et al.  Mitochondria, telomeres and cell senescence , 2005, Experimental Gerontology.

[274]  E. Hiyama,et al.  Telomere and telomerase in stem cells , 2007, British Journal of Cancer.

[275]  A. V. D. Van Der Zee,et al.  Lack of telomerase RNA gene hTERC expression in alternative lengthening of telomeres cells is associated with methylation of the hTERC promoter. , 2001, Cancer research.

[276]  T. Cech,et al.  Structure of human POT1 bound to telomeric single-stranded DNA provides a model for chromosome end-protection , 2004, Nature Structural &Molecular Biology.

[277]  B. Gilchrest,et al.  A role for WRN in telomere-based DNA damage responses , 2006, Proceedings of the National Academy of Sciences.

[278]  Kou-Juey Wu,et al.  Involvement of Topoisomerase III in Telomere-Telomere Recombination* , 2006, Journal of Biological Chemistry.

[279]  Jean-Louis Mergny,et al.  Selective recognition of G-qQuadruplex telomeric DNA by a bis(quinacridine) macrocycle. , 2003, Journal of the American Chemical Society.

[280]  M. Zanetti,et al.  Journal of Translational Medicine BioMed Central , 2006 .

[281]  Victor V Lobanenkov,et al.  Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene , 2007, Nucleic acids research.

[282]  J. Mergny,et al.  Highly efficient G-quadruplex recognition by bisquinolinium compounds. , 2007, Journal of the American Chemical Society.

[283]  D. Corey,et al.  Inhibition of telomerase by 2'-O-(2-methoxyethyl) RNA oligomers: effect of length, phosphorothioate substitution and time inside cells. , 2001, Nucleic acids research.

[284]  S. Neidle,et al.  Inhibition of human telomerase by a G-quadruplex-interactive compound. , 1997, Journal of medicinal chemistry.

[285]  A. Franchi,et al.  Azidothymidine Induces Apoptosis and Inhibits Cell Growth and Telomerase Activity of Human Parathyroid Cancer Cells in Culture , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[286]  J. Mergny,et al.  The development of telomerase inhibitors: the G-quartet approach. , 1999, Anti-cancer drug design.

[287]  T. Lange,et al.  Recent Expansion of the Telomeric Complex in Rodents: Two Distinct POT1 Proteins Protect Mouse Telomeres , 2006, Cell.

[288]  N. O'Neil,et al.  Homologous Recombination Is Required for Genome Stability in the Absence of DOG-1 in Caenorhabditis elegans , 2006, Genetics.

[289]  D. Kaul,et al.  Receptor Ck-dependent signaling regulates hTERT gene transcription , 2006, BMC Cell Biology.

[290]  Y. Kondo,et al.  Treatment of bladder cancer cells in vitro and in vivo with 2–5A antisense telomerase RNA , 2001, Gene Therapy.

[291]  T. Kirkwood,et al.  Mitochondrial Dysfunction Accounts for the Stochastic Heterogeneity in Telomere-Dependent Senescence , 2007, PLoS biology.

[292]  T. Lange,et al.  Ku70 stimulates fusion of dysfunctional telomeres yet protects chromosome ends from homologous recombination , 2006, Nature Cell Biology.

[293]  Yung-Hyun Choi,et al.  Induction of apoptosis and inhibition of telomerase activity by trichostatin A, a histone deacetylase inhibitor, in human leukemic U937 cells. , 2007, Experimental and molecular pathology.

[294]  M. Stevens,et al.  Potent inhibition of telomerase by small-molecule pentacyclic acridines capable of interacting with G-quadruplexes. , 2001, Molecular pharmacology.

[295]  C. Greider,et al.  Regulation of telomere elongation by the cyclin-dependent kinase CDK1. , 2006, Molecular cell.

[296]  S. Neidle,et al.  Human telomerase inhibition by regioisomeric disubstituted amidoanthracene-9,10-diones. , 1998, Journal of medicinal chemistry.

[297]  R. Wheelhouse,et al.  Cationic Porphyrins as Telomerase Inhibitors: the Interaction of Tetra-(N-methyl-4-pyridyl)porphine with Quadruplex DNA , 1998 .

[298]  J. Shay,et al.  Human telomeres have different overhang sizes at leading versus lagging strands. , 2006, Molecular cell.

[299]  J. Mergny,et al.  Ethidium derivatives bind to G-quartets, inhibit telomerase and act as fluorescent probes for quadruplexes. , 2001, Nucleic acids research.

[300]  S. Kulkarni,et al.  The effect of TERC haploinsufficiency on the inheritance of telomere length. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[301]  N. Kakazu,et al.  Rad54 is dispensable for the ALT pathway , 2006, Genes to cells : devoted to molecular & cellular mechanisms.

[302]  K. Rudolph,et al.  Telomeres and telomerase in cancer stem cells. , 2006, European journal of cancer.

[303]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[304]  B. Gilchrest,et al.  Evidence that exposure of the telomere 3′ overhang sequence induces senescence , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[305]  Yung-Hyun Choi,et al.  Induction of Apoptosis by (Z)-Stellettic Acid C, an Acetylenic Acid from the Sponge Stelletta sp., Is Associated with Inhibition of Telomerase Activity in Human Leukemic U937 Cells , 2007, Chemotherapy.

[306]  M. Boxer,et al.  Tri-, tetra- and heptacyclic perylene analogues as new potential antineoplastic agents based on DNA telomerase inhibition. , 2007, Bioorganic & medicinal chemistry.

[307]  D. V. Von Hoff,et al.  Design and synthesis of fluoroquinophenoxazines that interact with human telomeric G-quadruplexes and their biological effects. , 2001, Molecular cancer therapeutics.

[308]  C. Harley,et al.  A novel telomerase template antagonist (GRN163) as a potential anticancer agent. , 2003, Cancer research.

[309]  E. Gilson,et al.  TRF2 inhibition triggers apoptosis and reduces tumourigenicity of human melanoma cells. , 2006, European journal of cancer.

[310]  H. Dombret,et al.  Telomerase targeting by retinoids in cells from patients with myeloid leukemias of various subtypes, not only APL , 2006, Leukemia.

[311]  W. Hahn,et al.  Erosion of the telomeric single-strand overhang at replicative senescence , 2003, Nature Genetics.

[312]  邓伟平,et al.  Dyskeratosis congenita , 2007 .

[313]  O. Fedoroff,et al.  NMR-Based model of a telomerase-inhibiting compound bound to G-quadruplex DNA. , 1998, Biochemistry.

[314]  Stephen Neidle,et al.  A G-quadruplex telomere targeting agent produces p16-associated senescence and chromosomal fusions in human prostate cancer cells. , 2004, Molecular cancer therapeutics.

[315]  Hsu-Shan Huang,et al.  Human telomerase inhibition and cytotoxicity of regioisomeric disubstituted amidoanthraquinones and aminoanthraquinones. , 2005, Bioorganic & medicinal chemistry.

[316]  T. Lange,et al.  Shelterin: the protein complex that shapes and safeguards human telomeres , 2005 .

[317]  Tzu-chien V. Wang,et al.  Potent inhibition of human telomerase by U-73122. , 2006, Journal of biomedical science.

[318]  A. Burger.  Highlights in experimental therapeutics. , 2007, Cancer letters.

[319]  P. Kruk,et al.  Vitamin E suppresses telomerase activity in ovarian cancer cells. , 2007, Cancer detection and prevention.

[320]  B. Guyen,et al.  Synthesis, biophysical and biological evaluation of 3,6-bis-amidoacridines with extended 9-anilino substituents as potent G-quadruplex-binding telomerase inhibitors. , 2004, Bioorganic & medicinal chemistry letters.

[321]  I. Dokal,et al.  Dyskeratosis congenita: telomerase, telomeres and anticipation. , 2005, Current opinion in genetics & development.

[322]  Federica Briatore,et al.  4-Hydroxynonenal inhibits telomerase activity and hTERT expression in human leukemic cell lines. , 2006, Free radical biology & medicine.

[323]  C. A. Theimer,et al.  Structure and function of telomerase RNA. , 2006, Current opinion in structural biology.

[324]  N. Maizels,et al.  Intracellular transcription of G-rich DNAs induces formation of G-loops, novel structures containing G4 DNA. , 2004, Genes & development.

[325]  J. Griffith,et al.  T‐loop assembly in vitro involves binding of TRF2 near the 3′ telomeric overhang , 2001, The EMBO journal.

[326]  J. Shay,et al.  Telomerase therapeutics for cancer: challenges and new directions , 2006, Nature Reviews Drug Discovery.

[327]  Shankar Balasubramanian,et al.  Targeting the single-strand G-rich overhang of telomeres with PNA inhibits cell growth and induces apoptosis of human immortal cells. , 2004, Experimental cell research.

[328]  Barbara Benassi,et al.  Biological Activity of the G-Quadruplex Ligand RHPS4 (3,11-Difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate) Is Associated with Telomere Capping Alteration , 2004, Molecular Pharmacology.

[329]  R. Silverman,et al.  Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA , 1998, Oncogene.

[330]  S. Neidle,et al.  Stabilization of G-quadruplex DNA by highly selective ligands via click chemistry. , 2006, Journal of the American Chemical Society.

[331]  U. Klotz,et al.  Biopharmaceutical Characterization of the Telomerase Inhibitor BRACO19 , 2006, Pharmaceutical Research.